Finnzymes, Genovis Sign US Distribution Pact | GenomeWeb

NEW YORK (GenomeWeb News) — Swedish biotech company Genovis said today that Finnzymes will take over US logistical operations and handle some promotions for Genovis products in the US.

Genovis offers RNAi, transfection, imaging, and antibody engineering products to biotechnology companies and academic researchers. Finnzymes develops PCR, quantitative real-time PCR, transposon, and RNA technologies, and it offers PCR instruments, reaction vessels, and DNA polymerases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.